High-fat diet-induced neuropathy of pre-diabetes and obesity: Effects of "healthy" diet and aldose reductase inhibition

Diabetes

Volumn 56, Issue 10, 2007, Pages 2598-2608

  Obrosova, Irina G ^a   Ilnytska, Olga ^a   Lyzogubov, Valeriy V ^a   Pavlov, Ivan A ^a   Mashtalir, Nazar ^a   Nadler, Jerry L ^b   Drel, Viktor R ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ADENOSINE DIPHOSPHATE RIBOSE; ALDEHYDE REDUCTASE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; FAT; FIDARESTAT; GLUCOSE; INSULIN; SORBITOL;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CLINICAL EVALUATION; DIABETIC NEUROPATHY; DRUG ACTIVITY; ENZYME INHIBITION; FEEDING; FEMALE; HYPERGLYCEMIA; HYPOALGESIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INTERVENTION STUDY; LIPID DIET; MOTOR NERVE CONDUCTION; MOUSE; NERVE CELL; NERVE CONDUCTION DISORDER; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE FUNCTION; NONHUMAN; OBESITY; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE CONDUCTION; SPINAL GANGLION;

ALDEHYDE REDUCTASE; ANIMALS; BODY TEMPERATURE REGULATION; DIABETIC NEUROPATHIES; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; FEMALE; IMIDAZOLIDINES; MICE; MICE, INBRED C57BL; NEURONS, AFFERENT; OBESITY; PREDIABETIC STATE; RADIOIMMUNOASSAY; SENSORY THRESHOLDS; TOUCH;

EID: 34547399482     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1176     Document Type: Article

References (50)

1. Yach D, Stuckler D, Brownell KD: Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12:62-66, 2006
2. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M: The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60:108-111, 2003
3. Reindel J, Zander E, Heinke P, Kohnert KD, Allwardt C, Kerner W: The metabolic syndrome in patients with type 1 diabetes mellitus: associations with cardiovascular risk factors and cardiovascular morbidity. Herz 29:463-469, 2004
4. Pittenger G, Mehrabyan A, Simmons K, Rice A, Dublin C, Barlow P, Vinik A: Small fiber neuropathy is associated with the metabolic syndrome. Metabolic Syndrome and Related Disorders 3:113-121, 2005
5. Becker J, Nora DB, Gomes I, String FF, Seitensus R, Panosso JS, Ehlers JC: An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 113:1429-1434, 2002
6. Landau ME, Barner KC, Campbell WW: Effect of body mass index on ulnar nerve conduction velocity, ulnar neuropathy at the elbow, and carpal tunnel syndrome. Muscle Nerve 32:360-363, 2005
7. Bland JD: The relationship of obesity, age, and carpal tunnel syndrome: more complex than was thought? Muscle Nerve 32:527-532, 2005
8. Miscio G, Guastamacchia G, Brunani A, Priano L, Baudo S, Mauro A: Obesity and peripheral neuropathy risk: a dangerous liaison. J Peripher Nerv Syst 10:354-358, 2005
9. Singleton JR, Smith AG, Russell J, Feldman EL: Polyneuropathy with impaired glucose tolerance: implications for diagnosis and therapy. Curr Treat Options Neurol 7:33-42, 2005
10. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Poll D, Bixby B, Howard J, Singleton JR: Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29:1294-1299, 2006
11. Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA: Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 289:E113-E122, 2005
12. Obrosova IG, Fathallah L, Lang HJ, Greene DA: Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study. Diabetologia 42:1187-1194, 1999
13. Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabo C, Stevens MJ: Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53:711-720, 2004
14. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63, 1994
15. Calcutt NA, Freshwater JD, Mizisin AP: Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47:718-724, 2004
16. Ilnytska O, Lyzogubov VV, Stevens MJ, Drel VR, Mashtalir N, Pacher P, Yorek MA, Obrosova IG: Poly(ADP-Ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 55:1686-1694, 2006
17. Malmberg AB, Mizisin AP, Calcutt NA, von Stein T, Robbins WR, Bley KR: Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 111:360-367, 2004
18. Yagihashi S, Yamagishi SI, Wada Ri R, Baba M, Hohman TC, Yabe-Nishimura C, Kokai Y: Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 124:2448-2458, 2001
19. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. 1979. Biotechnology 24:145-149, 1992
20. Gao Z, Wang ZQ, Zhang X, Butler AA, Zuberi A, Gawronska-Kozak B, Lefevre M, York DA, Ravussin E, Berthoud HR, McGuinness OP, Cefalu WT, Ye J Inactivation of PKC{theta} leads to increased susceptibility to obesity and dietary insulin resistance in mice. Am J Physiol Endocrinol Metab 292:E94-E91, 2007
21. Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24:1225-1228, 2001
22. Smith AG, Ramachandran P, Tripp S, Singleton JR: Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701-1704, 2001
23. Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Naruse K, Kasuya Y, Mizubayashi R, Miwa K, Yasuda Y, Kamiya H, Ienaga K, Sakakibara F, Koh N, Hotta N: A protein kinase C β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48:2090-2095, 1999
24. Ho EC, Lam KS, Chen YS, Yip JC, Arvindakshan M, Yamagishi S, Yagihashi S, Oates PJ, Ellery CA, Chung SS, Chung SK: Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 55:1946-1953, 2006
25. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167, 1995
26. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA: Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006-1015, 2000
27. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA: Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50:1927-1937, 2001
28. Cameron NE, Tuck Z, McCabe L, Cotter MA: Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia 44:1161-1169, 2001
29. Obrosova IG, Mabley JG, Zsengeller Z, Charniauskaya T, Abatan OI, Groves JT, Szabo C: Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J 19:401-403, 2005
30. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA: Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental dabetic neuropathy: the relation is revisited. Diabetes 54:3435-3441, 2005
31. Li F, Szabo C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, Stevens MJ, Obrosova IG: Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 47:710-717, 2004
32. Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, Lyzogubov VV, Obrosova IG: The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55:3335-3343, 2006
33. Hwang YC, Kaneko M, Bakr S, Liao H, Lu Y, Lewis ER, Yan S, Ii S, Itakura M, Rui L, Skopicki H, Homma S, Schmidt AM, Oates PJ, Szabolcs M, Ramasamy R: Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J 18:1192-1199, 2004
34. Kaneko M, Bucciarelli L, Hwang YC, Lee L, Yan SF, Schmidt AM, Ramasamy R: Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Ann N Y Acad Sci 1043:702-709, 2005
35. Li Q, Gomez T, Anathakrishnan R, Kaneko M, Bakr S, Hallam K, Vannucci S, Schmidt AM, Ramasamy R: Vulnerability of myocardium to ischemic injury in aging: role of polyol pathway (Abstract). Circulation 112 (Suppl. 2):17, 2005
36. Hallam K, Gomez T, Li Q, Ananthakrishnan R, Yan S, Schmidt AM, Ramasamy R: Polyol pathway inhibition improves age-related vascular dysfunction in rats (Abstract). Experimental Biology 18:C276, 2006
37. Hounsom L, Corder R, Patel J, Tomlinson DR: Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia 44:424-428, 2001
38. Purves T, Middlemas A, Agthong S, Jude EB, Boulton AJ, Fernyhough P, Tomlinson DR: A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15:2508-2514, 2001
39. Pertovaara A, Wei H, Kalm J, Ruotsalainen M: Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties. Exp Neurol 167:425-434, 2001
40. Li F, Abatan OI, Kim H, Burnett D, Larkin D, Obrosova IG, Stevens MJ: Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol Dis 22:669-676, 2006
41. Ametov AS, Bnov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D, SYDNEY Trial Study Group: The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26:770-776, 2003
42. Ha HC, Hester LD, Snyder SH: Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A 99:3270-3275, 2002
43. Jagtap P, Szabo C: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421-440, 2005
44. Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabo C: Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7:108-113, 2001
45. Zheng L, Szabo C, Kern TS: Poly(ADP-Ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-κB. Diabetes 53:2960-2967, 2004
46. Szabo C, Zanchi A, Komjati K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, Veves A: Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 106:2680-2686, 2002
47. Natarajan R, Nadler JL: Lipoxygenases and lipid signaling in vascular cells in diabetes. Front Biosci 8:s783-s795, 2003
48. Natarajan R, Nadler JL: Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 24:1-8, 2004
49. Kim YS, Xu ZG, Reddy MA, Li SL, Lanting L, Sharma K, Adler SG, Natarajan R: Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol 16:352-362, 2005
50. Obrosova IG, Lyzogubov VV, Marchand J, Bai F, Nadler JL, Drel VR: Role for 12/15-lipoxygenase in diabetic neuropathy (Abstract). Diabetes 55 (Suppl. 1):A188, 2006